MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
STEX
Streamex Corp.
There isn't enough reported data to score STEX yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
STEX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
STEX's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like STEX.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
STEX PE Valuation
STEX has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 6.3x next year's earnings.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
STEX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect STEX to return to profit, with revenue growing.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus STEX down 223%.
STEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.05 | — |
| Q3 2022 | -$7.13 | +$3.07 |
| Q2 2022 | -$7.90 | +$4.00 |
| Q1 2022 | -$8.99 | +$7.71 |
| Q4 2021 | -$9.58 | +$9.12 |
| Q3 2021 | -$10.20 | +$12.30 |
| Q2 2021 | -$11.90 | +$9.30 |
| Q1 2021 | -$16.70 | +$1.10 |
| Q4 2020 | -$18.70 | -$2.20 |
STEX is still losing money, but far less than before: $8.74 per share over the past year, against $22.50 at its worst in late 2020.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
STEX has the stronger quarterly revenue trend. Revenue is up 12% for MS versus up 1,015% for STEX.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over STEX on profitability, with a higher operating margin.
STEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $13K | +8.3% |
| Q1 2024 | $14K | +180% |
| Q4 2023 | $12K | -91% |
| Q3 2023 | $1K | -99% |
| Q1 2023 | $5K | -38% |
| Q4 2022 | $135K | +1588% |
| Q3 2022 | $135K | +25% |
| Q2 2022 | $8K | -96% |
STEX's revenue is recovering but still below its 2021 peak: $145,000 last quarter, up 1015% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12397% | N/A |
| Q2 2026 | -10384% | N/A |
| Q4 2024 | -9100% | +42292 points |
| Q2 2024 | -40708% | N/A |
| Q1 2024 | -24550% | +123170 points |
| Q4 2023 | -51392% | -46208 points |
| Q3 2023 | -405100% | -400296 points |
| Q1 2023 | -147720% | -46908 points |
STEX's operating margin was −12397% last quarter, up 12153 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
STEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.1M | -$1.1M |
| Q2 2026 | -$11.7M | -$10.5M |
| Q1 2026 | -$10.2M | -$9.1M |
| Q4 2023 | -$2.9M | +$1.2M |
| Q3 2023 | -$3.9M | +$1.1M |
| Q2 2023 | -$5M | +$1.7M |
| Q1 2023 | -$5.7M | +$303K |
| Q4 2022 | -$4.2M | +$1.7M |
STEX has the edge over MS on cash flow, with more consistent year-over-year improvement.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over STEX on shareholder dilution, with a more favorable share count trend.
STEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +3.3M shares |
| 1 year | +569% | +158M shares |
| 3 years | +2672% | +179M shares |
| 5 years | +6542% | +183M shares |
STEX has 185M diluted shares, up 569% from a year ago.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
STEX Net Leverage
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
STEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 2.9 | Oversold |
STEX's weekly RSI is 34 (neutral) and its Stochastic is 3 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
STEX PE vs Financial Services Sector
STEX has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has stronger trend alignment. MS is above 3 of 5 weekly averages versus STEX above 0 of 3.
STEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.46 | 33% below |
| 20 week MA | $0.66 | 53% below |
| 50 week MA | $1.52 | 80% below |
STEX is in a downtrend: it's below all three of its weekly moving averages, and 80% below its 50-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over STEX on returns for 2026, with the stronger performance.
STEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $6.27 | $3.14 | -50% |
| 2026 YTD | $3.14 | $0.31 | -90% |
STEX has finished every year since 2025 lower, and it's down 90% so far in 2026.